Paper9533769
Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system.
Fulda S and 3 others. Int J Cancer, 1998. Cited by 150 papers, by iCite.
Cite this record
ConductScience Library. Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system. Papers, record 9533769. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9533769
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| fas Receptor | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Cysteine Endopeptidases | |
| Dose-Response Relationship, Drug | |
| Fluorescence | |
| Humans | |
| Time Factors | |
| Tumor Cells, Cultured |
Source PubMed
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40868135 | Mechanism of RCD and the Role of Different Death Signaling Pathways in Cancer. | Biomedicines | 2025 | https://conductscience.org/library/papers/40868135 | PubMed |
| 40678726 | Potential value and cardiovascular risks of programmed cell death in cancer treatment. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40678726 | PubMed |
| 39319154 | Synthesis and in vitro evaluation of cross-linked tragacanthin nanofibers as implants for delivery of cisplatin to hepatocellular carcinoma. | Heliyon | 2024 | https://conductscience.org/library/papers/39319154 | PubMed |
| 38264532 | Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and hematological tumors. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38264532 | PubMed |
| 35165859 | Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors. | Exp Suppl | 2022 | https://conductscience.org/library/papers/35165859 | PubMed |
| 31652776 | Destined to Die: Apoptosis and Pediatric Cancers. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31652776 | PubMed |
| 28177892 | Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis. | Oncotarget | 2017 | https://conductscience.org/library/papers/28177892 | PubMed |
| 26327844 | Mitochondrial dysfunction in cancer. | Prz Menopauzalny | 2014 | https://conductscience.org/library/papers/26327844 | PubMed |
| 25246270 | Human-gyrovirus-Apoptin triggers mitochondrial death pathway--Nur77 is required for apoptosis triggering. | Neoplasia | 2014 | https://conductscience.org/library/papers/25246270 | PubMed |
| 24648686 | Combined treatment of murine fibrosarcoma with chemotherapy (Paclitaxel), radiotherapy, and intratumoral injection of dendritic cells. | Ann Dermatol | 2014 | https://conductscience.org/library/papers/24648686 | PubMed |
| 24128051 | Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing. | Immunology | 2014 | https://conductscience.org/library/papers/24128051 | PubMed |
| 23817665 | β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK. | Int J Oncol | 2013 | https://conductscience.org/library/papers/23817665 | PubMed |
| 23441073 | Regulation of cell death in cancer-possible implications for immunotherapy. | Front Oncol | 2013 | https://conductscience.org/library/papers/23441073 | PubMed |
| 23165211 | Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent. | Cell Cycle | 2012 | https://conductscience.org/library/papers/23165211 | PubMed |
| 21943236 | Apoptosis in cancer: from pathogenesis to treatment. | J Exp Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21943236 | PubMed |
| 21509038 | Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway. | Cell Death Dis | 2011 | https://conductscience.org/library/papers/21509038 | PubMed |
| 20182539 | Evasion of apoptosis as a cellular stress response in cancer. | Int J Cell Biol | 2010 | https://conductscience.org/library/papers/20182539 | PubMed |
| 20182529 | Cellular stress responses: cell survival and cell death. | Int J Cell Biol | 2010 | https://conductscience.org/library/papers/20182529 | PubMed |
| 20013802 | Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis. | Int J Cancer | 2010 | https://conductscience.org/library/papers/20013802 | PubMed |
| 19381670 | A cDNA microarray analysis identifies 52 genes associated with cis-diamminedichloroplatinum susceptibility in head and neck squamous cell carcinoma cell lines. | Eur Arch Otorhinolaryngol | 2010 | https://conductscience.org/library/papers/19381670 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| CASP1 | 834 | PubTator's text mining | https://conductscience.org/library/genes/834 | NCBI Gene |
| FAS | 355 | PubTator's text mining | https://conductscience.org/library/genes/355 | NCBI Gene |
| FASLG | 356 | PubTator's text mining | https://conductscience.org/library/genes/356 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9533769
GET https://conductscience.org/api/papers/v1/9533769/cited_by?page=2